Adaptive Biotechnologies Corporation
DE ˙ MUN ˙ US00650F1093
12,86 € ↑0,04 (0,27%)
2026-06-02
DEL PRIS
SecurityDE:1HM / Adaptive Biotechnologies Corporation
InstitutionUBS Group AG
Latest Disclosed Ownership225,986 shares
Latest Disclosed Value $ 3,136,686
UBS Group AG reports 55.86% decrease in ownership of 1HM / Adaptive Biotechnologies Corporation

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 225,986 shares of Adaptive Biotechnologies Corporation (DE:1HM) valued at $2,517,484 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 511,927 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of -55.86% during the quarter. The current value of the position is $2,905,050 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 225,986 -285,941 -55.86 3,137 -62.28 0.0005
2026-01-29 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 511,927 257,947 101.56 8,314 118.82 0.0013
2025-11-13 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 253,980 -201,426 -44.23 3,800 -28.39 0.0006
2025-08-14 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 455,406 179,789 65.23 5,305 159.16 0.0009
2025-05-13 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 275,617 -121,641 -30.62 2,048 -14.03 0.0004
2025-02-14 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 397,258 324,107 443.07 2,382 536.63 0.0004
2024-11-14 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 73,151 16,520 29.17 375 82.44 0.0001
2024-08-14 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 56,631 -86,984 -60.57 205 -55.53 0.0001
2024-05-13 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 143,615 11,095 8.37 461 -28.97 0.0001
2024-02-09 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 132,520 42,202 46.73 649 31.91 0.0002
2023-11-09 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 90,318 -12,023 -11.75 492 -28.28 0.0002
2023-08-11 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 102,341 15,483 17.83 687 -10.44 0.0002
2023-05-12 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 86,858 24,722 39.79 767 61.60 0.0003
2023-02-08 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 62,136 35,131 130.09 475 145.60 0.0002
2022-11-10 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 27,005 1,725 6.82 193 -5.85 0.0001
2022-08-10 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 25,280 -24,372 -49.09 205 -70.29 0.0001
2022-05-16 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 49,652 50 0.10 690 -50.43 0.0002
2022-02-14 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 49,602 -2,456 -4.72 1,392 -21.31 0.0004
2021-11-15 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 52,058 36,761 240.32 1,769 183.04 0.0006
2021-08-13 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 15,297 -6,684 -30.41 625 -29.38 0.0002
2021-05-12 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 21,981 -986 -4.29 885 -34.83 0.0003
2021-02-11 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 22,967 -3,711 -13.91 1,358 4.70 0.0005
2020-11-12 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 26,678 3,666 15.93 1,297 16.53 0.0005
2020-07-31 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 23,012 -3,706 -13.87 1,113 50.00 0.0005
2020-05-01 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 26,718 16,788 169.06 742 149.83 0.0003
2020-02-14 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 9,930 -2,211 -18.21 297 -20.80 0.0001
2019-11-14 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 12,141 12,141 375 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.